Diagnos Valuation

ADK Stock  CAD 0.34  0.01  2.86%   
Diagnos seems to be overvalued based on Macroaxis valuation methodology. Our model computes the value of Diagnos from reviewing the firm fundamentals such as Operating Margin of (15.76) %, current valuation of 32.58 M, and Shares Outstanding of 95 M as well as analyzing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Diagnos' valuation include:
Price Book
54.6059
Enterprise Value
32.6 M
Enterprise Value Ebitda
(6.16)
Price Sales
194.6137
Forward PE
9.7466
Overvalued
Today
0.34
Please note that Diagnos' price fluctuation is out of control at this time. Calculation of the real value of Diagnos is based on 3 months time horizon. Increasing Diagnos' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Diagnos stock is determined by what a typical buyer is willing to pay for full or partial control of Diagnos. Since Diagnos is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Diagnos Stock. However, Diagnos' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  0.34 Real  0.27 Hype  0.34
The intrinsic value of Diagnos' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Diagnos' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
0.27
Real Value
3.74
Upside
Estimating the potential upside or downside of Diagnos helps investors to forecast how Diagnos stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Diagnos more accurately as focusing exclusively on Diagnos' fundamentals will not take into account other important factors:
Earnings
Estimates (0)
LowProjectedHigh
0.000.000.00
Details
Hype
Prediction
LowEstimatedHigh
0.020.343.81
Details
Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Diagnos' intrinsic value based on its ongoing forecasts of Diagnos' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Diagnos' closest peers.

Diagnos Cash

381,081

Diagnos Valuation Trend

Analysing the historical paterns of Diagnos' enterprise value and its market capitalization is a good way to estimate and gauge the value of Diagnos over time and is usually enough for investors to make rational market timing decisions.

Diagnos Total Value Analysis

Diagnos is presently estimated to have takeover price of 32.58 M with market capitalization of 31.82 M, debt of 3.19 M, and cash on hands of 97.5 K. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Diagnos fundamentals before making investing decisions based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
32.58 M
31.82 M
3.19 M
97.5 K

Diagnos Investor Information

About 14.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.04. Diagnos last dividend was issued on the 24th of April 2019. The entity had 1:10 split on the 24th of April 2019. Based on the key indicators related to Diagnos' liquidity, profitability, solvency, and operating efficiency, Diagnos may be sliding down financialy. It has an above-average odds of going through some form of financial crisis next quarter.

Diagnos Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Diagnos has an asset utilization ratio of 25.63 percent. This indicates that the Company is making C$0.26 for each dollar of assets. An increasing asset utilization means that Diagnos is more efficient with each dollar of assets it utilizes for everyday operations.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid

Diagnos Ownership Allocation

Diagnos holds a total of 95 Million outstanding shares. Diagnos shows 14.41 percent of its outstanding shares held by insiders and 0.01 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Diagnos Profitability Analysis

The company reported the revenue of 170.16 K. Net Loss for the year was (3.12 M) with loss before overhead, payroll, taxes, and interest of (753.81 K).

About Diagnos Valuation

Our relative valuation model uses a comparative analysis of Diagnos. We calculate exposure to Diagnos's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Diagnos's related companies.
Last ReportedProjected for Next Year
Gross Profit-754.1 K-716.4 K
Pretax Profit Margin(16.51)(17.33)
Operating Profit Margin(14.20)(14.91)
Net Loss(16.51)(17.33)
Gross Profit Margin 0.24  0.25 

Additional Tools for Diagnos Stock Analysis

When running Diagnos' price analysis, check to measure Diagnos' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Diagnos is operating at the current time. Most of Diagnos' value examination focuses on studying past and present price action to predict the probability of Diagnos' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Diagnos' price. Additionally, you may evaluate how the addition of Diagnos to your portfolios can decrease your overall portfolio volatility.